Pomdoctor Limited (POM)
NASDAQ: POM · Real-Time Price · USD
0.436
+0.186 (74.11%)
At close: Mar 9, 2026, 4:00 PM EDT
0.320
-0.117 (-26.74%)
After-hours: Mar 9, 2026, 6:40 PM EDT
Company Description
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products.
The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products.
The company’s business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants.
The company was founded in 2010 and is headquartered in Guangzhou, China.
Pomdoctor Limited
| Country | China |
| Founded | 2015 |
| IPO Date | Oct 8, 2025 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 156 |
| CEO | Zhenyang Shi |
Contact Details
Address: Yongxu Industrial Park, No.19-23 Hejing Road Guangzhou, 510000 China | |
| Phone | 86 20 6231 2277 |
| Website | 7lk.com |
Stock Details
| Ticker Symbol | POM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| IPO Price | $4.00 |
| CIK Code | 0001877971 |
| CUSIP Number | 73181R108 |
| ISIN Number | US73181R1086 |
| SIC Code | 5900 |
Key Executives
| Name | Position |
|---|---|
| Zhenyang Shi | Co-Founder, Chief Executive Officer and Chairman |
| Li Xu | Co-Founder and Chief Financial Officer |
| Guoji Luo | Vice President and Director |
| Dexiang Wei | Vice President |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 4, 2026 | 6-K | Report of foreign issuer |
| Feb 2, 2026 | 6-K | Report of foreign issuer |
| Jan 16, 2026 | 6-K | Report of foreign issuer |
| Dec 3, 2025 | 6-K | Report of foreign issuer |
| Nov 5, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Oct 9, 2025 | 424B4 | Prospectus |
| Oct 7, 2025 | CERT | Certification by an exchange approving securities for listing |
| Sep 30, 2025 | EFFECT | Notice of Effectiveness |
| Sep 30, 2025 | EFFECT | Notice of Effectiveness |
| Sep 26, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |